Patches, liquids, and a newly approved triple reuptake inhibitor are expanding the ADHD treatment toolkit. The panel discusses when to reach beyond familiar medications and how to build patient trust in doing so. — From Psychiatric Times articles Read More
New ADHD Formulations, Patches, and Patient Trust
Integrated Psychiatric Consultants
Office Hours:Mon-Fri, 9 a.m. - 5 p.m. CT